BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27121213)

  • 1. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
    Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
    Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion of BLIMP-1
    Ward-Hartstonge KA; McCall JL; McCulloch TR; Kamps AK; Girardin A; Cretney E; Munro FM; Kemp RA
    Cancer Immunol Immunother; 2017 Apr; 66(4):515-522. PubMed ID: 28116480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of the tumor immune microenvironment for staging and therapeutics.
    Taube JM; Galon J; Sholl LM; Rodig SJ; Cottrell TR; Giraldo NA; Baras AS; Patel SS; Anders RA; Rimm DL; Cimino-Mathews A
    Mod Pathol; 2018 Feb; 31(2):214-234. PubMed ID: 29192647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Immunoscore in Colorectal Carcinomas.
    Imen H; Amira H; Fatma K; Raja J; Mariem S; Haithem Z; Ehsene BB; Aschraf C
    Int J Surg Pathol; 2024 Feb; 32(1):58-65. PubMed ID: 37097904
    [No Abstract]   [Full Text] [Related]  

  • 5. Could immunoscore improve the prognostic and therapeutic management in patients with solid tumors?
    Xu JL; Yang MX; Lan HR; Jin KT
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110981. PubMed ID: 37769534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors.
    Eljilany I; Saghand PG; Chen J; Ratan A; McCarter M; Carpten J; Colman H; Ikeguchi AP; Puzanov I; Arnold S; Churchman M; Hwu P; Conejo-Garcia J; Dalton WS; Weiner GJ; El Naqa IM; Tarhini AA
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dataset of tumour-infiltrating lymphocytes in colorectal cancer patients using limited resources.
    Hasnaoui A; Helal I; Ben Azouz Z; Hmidi A; Jouini R; Chadli-Debbiche A
    Database (Oxford); 2023 Dec; 2023():0. PubMed ID: 38104276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan.
    Komatsu S; Otsuji E
    Ann Gastroenterol Surg; 2019 Nov; 3(6):581-591. PubMed ID: 31788646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015.
    Galon J; Fox BA; Bifulco CB; Masucci G; Rau T; Botti G; Marincola FM; Ciliberto G; Pages F; Ascierto PA; Capone M
    J Transl Med; 2016 Sep; 14():273. PubMed ID: 27650038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional Support for the Introduction of Immune Cell Quantification in Colorectal Cancer Classification.
    Ferris RL; Galon J
    J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27172904
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Focus on the Immunoscore and its potential clinical implications].
    El Sissy C; Marliot F; Haicheur N; Kirilovsky A; Scripcariu D; Lagorce-Pagès C; Galon J; Pagès F
    Ann Pathol; 2017 Feb; 37(1):29-38. PubMed ID: 28161000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer.
    Park JH; McMillan DC; Edwards J; Horgan PG; Roxburgh CS
    Oncoimmunology; 2016 Mar; 5(3):e1098801. PubMed ID: 27141369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers immune monitoring technology primer: Immunoscore® Colon.
    Hermitte F
    J Immunother Cancer; 2016; 4():57. PubMed ID: 27660711
    [No Abstract]   [Full Text] [Related]  

  • 15. Towards tumor immunodiagnostics.
    Kourea H; Kotoula V
    Ann Transl Med; 2016 Jul; 4(14):263. PubMed ID: 27563650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
    Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
    Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy.
    Farsaci B; Donahue RN; Grenga I; Lepone LM; Kim PS; Dempsey B; Siebert JC; Ibrahim NK; Madan RA; Heery CR; Gulley JL; Schlom J
    Cancer Immunol Res; 2016 Sep; 4(9):755-65. PubMed ID: 27485137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
    Masugi Y; Nishihara R; Yang J; Mima K; da Silva A; Shi Y; Inamura K; Cao Y; Song M; Nowak JA; Liao X; Nosho K; Chan AT; Giannakis M; Bass AJ; Hodi FS; Freeman GJ; Rodig S; Fuchs CS; Qian ZR; Ogino S
    Gut; 2017 Aug; 66(8):1463-1473. PubMed ID: 27196573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.
    Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS
    Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule.
    Kaufman HL; Butterfield LH; Coulie PG; Demaria S; Ferris RL; Galon J; Khleif SN; Mellman I; Ohashi PS; Overwijk WW; Topalian SL; Marincola FM
    J Immunother Cancer; 2016; 4():37. PubMed ID: 27330810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.